The information contained in the Organizational Database (ODB) is provided for informational purposes only. There is no implied endorsement by NORD. NORD does not promote or endorse participation in any specific organization. The information is subject to change without notice. Every effort is made to ensure that the details for each entry are as current as possible.
Global and Regional Asperger's Syndrome Partnership (GRASP)
666 Broadway, Suite 830
New York, NY 10012
The Global and Regional Asperger's Syndrome Partnership (GRASP) is a non-profit organization whose mission is to increase public awareness of Asperger Syndrome and High-Functioning Autism; to provide those with Asperger Syndrome and High-Funcioning Autism with a mutually-supportive community that is both comforting and challenging to one another; to teach its members who are diagnosed with Asperger Syndrome and High-Functioning Autism, through education and understanding, to maximize the talents and minimize the damage brought on by their condition, to harness the unique capabilities and celebrate the accomplishments inherent in their community, and to reduce the harm caused when their behavior diverges from non-autistic norms; to become a national, and eventually, international force for change in improving the live of those with Asperger Syndrome and High-Functioning Autism. Asperger's syndrome is a neuropsychiatric disorder. Children with this disorder experience the inability to understand the feelings of others, abnormal single-mindedness, lack of verbal skills, insensitivity to social cues, withdrawal and obsessive indulgence in special interests. Many clinicians believe that Asperger's syndrome is a sub-type of autism that is differentiated by a later onset (i.e., it is usually not recognized before 30 months of age) and by the fact that speech generally is not delayed, as it often is in children with autism. The exact cause of Asperger’s syndrome is unknown.
The National Organization for Rare Disorders (NORD) web site, its databases, and the contents thereof are copyrighted by NORD. No part of the NORD web site, databases, or the contents may be copied in any way, including but not limited to the following: electronically downloading, storing in a retrieval system, or redistributing for any commercial purposes without the express written permission of NORD. Permission is hereby granted to print one hard copy of the information on an individual disease for your personal use, provided that such content is in no way modified, and that credit for the source (NORD) and NORD’s copyright notice are included on the printed copy. Any other electronic reproduction or other printed versions are strictly prohibited.
NORD's Rare Disease Information Database is copyrighted and may not be published without the written consent of NORD.